Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase

MLA

Ryan M. Franke, et al. “Influence of Oct1/Oct2-Deficiency on Cisplatin-Induced Changes in Urinary N-Acetyl-Beta-D-Glucosaminidase.” Clinical Cancer Research, vol. 16, no. 16, Aug. 2010, pp. 4198–206. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c5e9ea9afa9988da80c77f00afc3d8cd&authtype=sso&custid=ns315887.

APA

Ryan M. Franke, Chaoxin Hu, Alex Sparreboom, Ron H.J. Mathijssen, Oliver Zolk, Kelly K. Filipski, Ashley M. Kosloske, & Cynthia S. Lancaster. (2010). Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase. Clinical Cancer Research, 16(16), 4198–4206.

Chicago

Ryan M. Franke, Chaoxin Hu, Alex Sparreboom, Ron H.J. Mathijssen, Oliver Zolk, Kelly K. Filipski, Ashley M. Kosloske, and Cynthia S. Lancaster. 2010. “Influence of Oct1/Oct2-Deficiency on Cisplatin-Induced Changes in Urinary N-Acetyl-Beta-D-Glucosaminidase.” Clinical Cancer Research 16 (16): 4198–4206. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c5e9ea9afa9988da80c77f00afc3d8cd&authtype=sso&custid=ns315887.